Salvage of locoregionally recurrent head and neck cancer: an NRG oncology working group review
Recommended Citation
Ward MC, Kang JJ, Saba NF, Campbell SR, Akhave NS, Chang SS, Spencer SA, Spreafico A, Hanna GJ, Yom SS, and Heron DE. Salvage of locoregionally recurrent head and neck cancer: an NRG oncology working group review. J Natl Cancer Inst 2026.
Document Type
Article
Publication Date
2-2-2026
Publication Title
Journal of the National Cancer Institute
Keywords
Locoregional recurrence; chemoimmunotherapy; head and neck; re-irradiation; salvage
Abstract
Despite decades of progress in the treatment of head and neck cancer, recurrence and second primary cancers continue to occur. The management of non-metastatic, locoregionally recurrent or second primary cancers is a complex multidisciplinary challenge that often occurs without guidance from robust clinical trials. In 2023, the NRG Oncology cooperative group created the Recurrent and Metastatic Working Group with the express directive to investigate how resources could optimally address the key questions for the recurrent and metastatic populations. Here, we present our view of the state of the science and present considerations for future investigations.
PubMed ID
41629764
ePublication
ePub ahead of print
